Skip to main content

Table 3.

Comparison of baseline characteristics depending on the viral response status at week 24.

Patient characteristics at baseline (n = 33) Viral response at week 24 (n = 19) Viral non-response at week 24 (n = 3) Intermediate viral response at week 24 (n = 11) Post hoc p value
ALT U/L, mean ± SD 114 ± 85 140 ± 10 109 ± 64 0.85∗, 0.98∗∗, 0.80∗∗∗
Age, years ± SD 49 ± 8 36 ± 9 47 ± 16 0.20∗, 0.93∗∗, 0.32∗∗∗
Cirrhosis, n 12/19 2/3 4/11 0.33 (overall group comparison)
Platelets ∗103/μl, median 133 158 130 0.52∗, 0.86∗∗, 0.65∗∗∗

∗Response vs. non-response, ∗∗Response vs. intermediate response, ∗∗∗Non-response vs. intermediate response.

Data were compared by univariate ANOVA followed by a Tukey post hoc test. A Pearson Chi-square test was used for the presence of cirrhosis.

ALT, alanine aminotransferase.